Hiroyuki Hasegawa
Direktor/Vorstandsmitglied bei Kamui Pharma, Inc.
Profil
Hiroyuki Hasegawa is currently a Director at Kamui Pharma, Inc. and was previously an Executive Officer & GM-Life Science Department at Mitsubishi UFJ Capital Co., Ltd.
He also served as an Outside Director at Veritas In Silico Inc. and Chordia Therapeutics, Inc.
Aktive Positionen von Hiroyuki Hasegawa
| Unternehmen | Position | Beginn |
|---|---|---|
Mitsubishi UFJ Capital Co., Ltd.
 Mitsubishi UFJ Capital Co., Ltd. Investment ManagersFinance Mitsubishi UFJ Capital Co., Ltd. (MUCAP) is a venture capital subsidiary of Mitsubishi UFJ Financial Group, Inc. (TSE: 8306; NYSE: MTU), founded in 1974. The firm is headquartered in Tokyo with additional offices in Nagoya and Osaka. | Private Equity Investor | 01.01.2004 |
Kamui Pharma, Inc.
 Kamui Pharma, Inc. Pharmaceuticals: MajorHealth Technology Kamui Pharma, Inc. is a pharmaceutical company based in Japan. The company's description is in Japanese, but it appears to focus on research and development in the pharmaceutical industry. The company was founded in 2018 by Naoki Ogawa, who has been the CEO since then. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Hiroyuki Hasegawa
| Unternehmen | Position | Ende |
|---|---|---|
| CHORDIA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | - |
| VERITAS IN SILICO INC. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VERITAS IN SILICO INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Mitsubishi UFJ Capital Co., Ltd.
Mitsubishi UFJ Capital Co., Ltd. Investment ManagersFinance Mitsubishi UFJ Capital Co., Ltd. (MUCAP) is a venture capital subsidiary of Mitsubishi UFJ Financial Group, Inc. (TSE: 8306; NYSE: MTU), founded in 1974. The firm is headquartered in Tokyo with additional offices in Nagoya and Osaka. | Finance |
Kamui Pharma, Inc.
Kamui Pharma, Inc. Pharmaceuticals: MajorHealth Technology Kamui Pharma, Inc. is a pharmaceutical company based in Japan. The company's description is in Japanese, but it appears to focus on research and development in the pharmaceutical industry. The company was founded in 2018 by Naoki Ogawa, who has been the CEO since then. | Health Technology |
Chordia Therapeutics, Inc.
 Chordia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chordia Therapeutics, Inc. engages in the research and development of novel therapies for cancers. It handles research and development of low-molecular-weight drugs with unprecedented new mechanisms of action in the oncology area. The company was founded by Hiroshi Miyake and Daisuke Morishita on October 12, 2017 and is headquartered in Fujisawa, Japan. | Health Technology |
